ϵͳÐÔºì°ßÀÇ´¯(systemic lupus erythematosus,SLE)ÊÇÒ»ÖÖ×ÔÉíÃâÒ߽鵼µÄÂýÐÔÑ×Ö¢ÐÔ¼²²¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬Æä·¢²¡»úÖƲ»Ã÷£¬£¬£¬£¬£¬£¬ÒÔ¶àϵͳÆ÷¹ÙË𺦼°¶àÖÖ×ÔÉí¿¹ÌåµÄ±¬·¢ÎªÖ÷ÒªÌص㡣¡£¡£¡£¡£¡£¡£
SLEËðÉËƵÂÊ×î¸ßµÄÆ÷¹ÙϵͳÊǼ¡Èâ¹Ç÷À¡¢ÉöÔà¡¢ÐÄѪ¹ÜºÍÉñ¾¾«Éñϵͳ£¬£¬£¬£¬£¬£¬×î¸ßµÄËðÉËÀÛ»ý±¬·¢ÔÚ¼²²¡µÄÇ°2Äê¡£¡£¡£¡£¡£¡£¡£
50~70%µÄSLE»¼ÕßÓе䷶µÄÉöÀÛ¼°ÁÙ´²ÌåÏÖ£¬£¬£¬£¬£¬£¬ÀÇ´¯ÉöÑ×(LN)ÊÇSLE·¢²¡ºÍסԺµÄÖ÷ÒªÔµ¹ÊÔÓÉ£¬£¬£¬£¬£¬£¬LNÏà¹ØµÄÉöË¥½ßÊÇSLEµÄÖ÷ÒªéæÃüÔµ¹ÊÔÓÉÖ®Ò»¡£¡£¡£¡£¡£¡£¡£
Îü¸½ÔÀí
DNAÃâÒßÎü¸½ÖùÊÇÔÚÌ¿»¯Ê÷Ö¬ÉÏÀο¿Ð¡Å£ÐØÏÙDNAÖƳÉDNAÃâÒßÎü¸½¼Á£¬£¬£¬£¬£¬£¬ÓëÖùÌåµÈ×é×°³ÉÃâÒßÎü¸½Öù£¬£¬£¬£¬£¬£¬¾ßÓжԿ¹DNA¿¹ÌåºË¿¹ÌåµÄÌØÒìÐÔʶ±ðºÍÎü¸½ÄÜÁ¦¡£¡£¡£¡£¡£¡£¡£
³£¼ûÎü¸½¼Æ»®[3-5]
²Î¿¼ÎÄÏ×£º
[1]ÀõÕ¼¹ú£¬£¬£¬£¬£¬£¬ÕÅ·î´º£¬£¬£¬£¬£¬£¬ÔøС·å.·çʪÃâÒßѧ[M].ÈËÃñ¾üÒ½³öÊéÉ磬£¬£¬£¬£¬£¬2014,91-93.
[2]Nossent J,Kiss E,Rozman B,et al.Disease activity and damage accrual during the early disease course in a multinationalinception cohort of patients with systemic lupus erythematosus[J].Lup,2010,19(8):949 -956.
[3]Áõ·²£¬£¬£¬£¬£¬£¬ÒüÞ±.DNAÃâÒßÎü¸½ÖÎÁÆС¶ùϵͳÐÔºì°ßÀÇ´¯¶ÔѪÇåD-¶þ¾ÛÌ壬£¬£¬£¬£¬£¬¶ù-23ˮƽµÄÓ°Ïì[J].Äϲý´óѧѧ±¨£ºÒ½Ñ§°æ£¬£¬£¬£¬£¬£¬2020,60(1):4.
[4]¼ÖÓ¨£¬£¬£¬£¬£¬£¬DNAÃâÒßÎü¸½ÑªÒº¹àÁ÷Æ÷ÖÎÁÆÀÇ´¯ÐÔÉöÑ×µÄЧ¹ûÊÓ²ì[J].ÖйúÏÖ´úÒ©ÎïÓ¦Ó㬣¬£¬£¬£¬£¬2018,12(17);3.
[5]×ó·¼·¼£¬£¬£¬£¬£¬£¬ÐíÇÙЦ£¬£¬£¬£¬£¬£¬Ô¬Ò㣬£¬£¬£¬£¬£¬µÈ£¬£¬£¬£¬£¬£¬ÃâÒßÎü¸½ÖÎÁÆϵͳÐÔºì°ßÀÇ´¯31ÀýÁÙ´²ÁÆЧÊÓ²ì[C]//ÌìÏ·çʪ²¡Ñ§Êõ¾Û»á.ÖйúÖÐÎ÷ҽ͎áѧ»á£¬£¬£¬£¬£¬£¬2015.
DNA230+HA280Ë«ÖØÎü¸½£¬£¬£¬£¬£¬£¬¿ìËÙɨ³ý
²Î¿¼ÎÄÏ×£º
[1]µØ½²¨£¬£¬£¬£¬£¬£¬¶ÅÅô£¬£¬£¬£¬£¬£¬ÃâÒßÎü¸½ÖÎÁƼ±ÐÔ¸ñÁÖ°ÍÀû×ÛºÏÕ÷×ÔÀý[1].ÌìÏÂ×îÐÂҽѧÐÅÏ¢ÎÄÕª£¬£¬£¬£¬£¬£¬2016,16(46):177-179.
[2]¶Ï볡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬ÕÔÁú±ó£¬£¬£¬£¬£¬£¬ÖìÉÜÄ꣬£¬£¬£¬£¬£¬µÈ.DNAÃâÒßÎü¸½ÖÎÁÆ×ÔÉíÃâÒßÐԸβ¡µÄÁÙ´²ÁÆЧ[J].Öаë¸Î´¥²¡ÔÓÖ¾£¬£¬£¬£¬£¬£¬2013,21(4):315-317.
[3]ÍõÉÕ¾ü£¬£¬£¬£¬£¬£¬º«¾Û·½£¬£¬£¬£¬£¬£¬¸êº£Ç࣬£¬£¬£¬£¬£¬µÈ.DNAÃâÒßÎü¸½ÖÎÁÆ×ÔÉíÃâÒßÐÔÑ×ÐÔ¼¡²¡µÄÁÙÄ©ÁÆЧ[J].ÊÊÓÃҽѧÔÓÖ¾£¬£¬£¬£¬£¬£¬2015,31(4):678-679.
[4]ÕÔÁúÃ㬣¬£¬£¬£¬£¬ÐÁÐ۲ȣ¬£¬£¬£¬£¬£¬ËïÓ껪£¬£¬£¬£¬£¬£¬µÈ.ÃâÒßÎüÉäÖÎÁÆÄÑÖÎÐÔÀà·çʪÊàŦÑ×µÄÁÙ´²Ó¦ÓÃ[J].ÖйúѪҺ¾»»¯£¬£¬£¬£¬£¬£¬2017,16(10):681-685.
[5]Õ;¯Õ£¬£¬£¬£¬£¬×¯Ó£¬£¬£¬£¬£¬ÁõÁ¿.DNAÃâÒßÎü¸½ÁÆ·¨ÖÎÁÆ»ý´¯¼äÖÊÐÔ·ÎÑ׵ĽüÆÚÁÆЧ¼°Çå¾²ÐÔÆÊÎöС¹ãÎ÷Ò½¿Æ´óѧѧ±¨£¬£¬£¬£¬£¬£¬2018,35(1):61-64.
[6]ÐÁæ㬣¬£¬£¬£¬£¬ÑªÒº¾»»¯ÍŽáDNAÃâÒ¹Îü¸½ÖιãÖØ֢ϵͳÐÔºì°à¶À¸ÐµÄЧ¹û[J].ÊÊÓÃÁÙ´²Õչ˻¤Ê¿Ñ§ÔÓÖ¾£¬£¬£¬£¬£¬£¬2019¡£¡£¡£¡£¡£¡£¡£(14):62-63.
[7]°¢Èð¾ê£¬£¬£¬£¬£¬£¬¶Ñ£¬£¬£¬£¬£¬Ðì´ïÁ¼£¬£¬£¬£¬£¬£¬µÈ.ѪҺ¹àÁ÷ÖÎÁƶùͯÖØÖ¢¹ýÃôÐÔº®°¸µÄÁÆЧÊÓ²ì[J].°²»Õҽѧ£¬£¬£¬£¬£¬£¬2014(6):721-723.
[8]±«Ïþ»Ô ·³¤ Îâ־ƽ ³ÌÏþÃà Óá»ÛÇÙ ê» ÎÄ.ѪҺ¹àÁ÷ÖÎÁÆÖØÖ¢Ò©ÕîÁÙ´²ÁÆЧÊÓ²ì[J],Öлª¼±ÕïҽѧÔÓÖ¾£¬£¬£¬£¬£¬£¬2016(25):97.
[9]ÁõÓñ·ç.ѪҺ¹àÁ÷ÔÚÌìðå´¯ÖÎÁÆÖеÄÓ¦ÓÃÓëÕչ˻¤Ê¿].½ñÊÀ»¤Ê¿(ÖÐ×Ô¿¯),2018,01(V.25):49-50.
[10]ÎâÈð¶÷£¬£¬£¬£¬£¬£¬»ÆÔÊ£¬£¬£¬£¬£¬£¬¼¯¹ð±æ.ѪҺ¹àÁ÷ÖÎÁÆÒøм²¡11ÀýµÄÁÆЧÊÓ²ì].¹ãÎ÷ҽѧ£¬£¬£¬£¬£¬£¬2009,31(010):1565-1566
